BioSpace News Archive

The Center for Breakthrough Medicines (CBM), a contract development, manufacturing, and testing organization (CDMO) is packaging their pre-clinical capabilities into an IND-enabling offering to help innovator companies manufacture high quality drug substance and drug product for pre-clinical studies needed for IND-enabling activities.

Anton Jorgensen, MD and Ortho San Antonio announced the first cases in the BalancedBack Total Joint Replacement pivotal clinical trial using the breakthrough 3Spine MOTUS device, as an alternative to lumbar spinal fusion surgery.

Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced its financial results for the fourth quarter and full year ending December 31, 2022.

Cyclacel Pharmaceuticals, Inc. today announced fourth quarter and full year 2022 financial results and provided a business update.

MaxCyte, Inc. today announced preliminary revenue results for the fourth quarter and full year 2022 and provided initial 2023 revenue guidance.

Apellis Pharmaceuticals , Inc. today announced that the company approved the grant of equity awards to 6 new employees with a grant date of March 1, 2023, as equity inducement awards outside of the company’s 2017 Stock Incentive Plan (but under the terms of the 2022 Inducement Stock Incentive Plan).

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter and year ended December 31, 2022, after the market close on Monday, March 20, 2023.

Cara Therapeutics, Inc. today announced financial results and operational highlights for the fourth quarter and full year ended December 31, 2022.

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its fourth quarter and full year ended December 31, 2022.

BridgeBio Pharma, Inc. announced today that it has commenced an underwritten public offering of $150 million of shares of its common stock.